trial
as of 2026-07-01Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
NCTId NCT00135772
at a glance
Phase — · Completed
Enrollment 100
Sponsored by National Institute on Drug Abuse (NIDA)
Primary completion 2004-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
100
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2003-10
Primary completion
2004-07
Eligibility
ALL · 18 Years · 70 Years
Interventions & indications
Sponsors
National Institute on Drug Abuse (NIDA)Lead Sponsor
Investigators
1
Jill M. Williams, M.D.Principal Investigator
Sites
1 total
Piscataway, United States
Facts & assertions
4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2004-07
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
indication
indication
indication
investigator
person